Revolution Medicines, Inc.
RVMD
$41.88
$1.463.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -697.51M | -600.09M | -567.06M | -519.21M | -484.27M |
| Total Depreciation and Amortization | 11.68M | 10.72M | 10.20M | 9.46M | 8.44M |
| Total Amortization of Deferred Charges | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M |
| Total Other Non-Cash Items | 43.36M | 30.43M | 36.52M | 32.38M | 33.50M |
| Change in Net Operating Assets | 50.06M | 406.00K | -20.46M | -33.53M | -7.51M |
| Cash from Operations | -591.31M | -557.44M | -539.71M | -509.79M | -448.74M |
| Capital Expenditure | -10.41M | -10.31M | -11.40M | -10.42M | -9.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -311.97M | -544.09M | -530.49M | -432.65M | -585.42M |
| Cash from Investing | -322.38M | -554.39M | -541.89M | -443.07M | -594.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 863.79M | 863.71M | 88.15M | 11.87M | 69.00M |
| Repurchase of Common Stock | -- | -- | -4.03M | -4.03M | -4.03M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.69M | 95.71M | 840.83M | 840.83M | 840.83M |
| Cash from Financing | 959.48M | 959.41M | 924.96M | 848.68M | 905.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.79M | -152.42M | -156.64M | -104.18M | -137.50M |